The mouse-lethal H5N1 influenza virus carrying the PB2-384L/443R/460M characteristics acquired in avian hosts can effectively utilize human ANP32A/B proteins

Research into H5N1 avian influenza has revealed a specific genetic signature that allows the virus to more effectively infect human hosts. By utilizing the PB2-384L/443R/460M mutation, certain H5N1 strains can bypass traditional adaptation requirements to interact with human ANP32A/B proteins, potentially increasing their pathogenic potential in humans.

How H5N1 viruses adapt to human proteins

Avian influenza viruses typically struggle to replicate in mammals because of species-specific proteins called ANP32A/B. These proteins act as a restriction barrier, limiting the function of the viral polymerase.

View this post on Instagram about Expert Insight, Samantha Carter

From Instagram — related to Expert Insight, Samantha Carter

To overcome this, viruses often acquire amino acid substitutions in the polymerase 2 (PB2) protein, such as E627K and D701N. These changes enhance compatibility with human ANP32A and ANP32B, which boosts replication efficiency and increases the virus’s potential to cause disease.

Did You Know? Certain H5N1 avian influenza viruses can establish productive human infections even without the common PB2-627K or PB2-701N adaptive mutations.

What makes the LN35 virus more lethal?

A study compared two genetically similar H5N1 viruses: A/chicken/LN/SD035/2018 (LN35) and A/duck/JL/S1261/2019 (JL261). While they share similarities, their impact on mice differed significantly.

Testing with single-gene reassortant viruses and mutants confirmed that the PB2-384L/443R/460M signature is the key. This specific combination of characteristics is what allows LN35 to maintain high lethality in mice.

Expert Insight: Samantha Carter notes that the ability of a virus to evolve these adaptations within avian hosts—before ever entering a human—significantly alters the risk profile. It suggests the virus doesn’t always need to “learn” how to infect humans after the jump occurs.

Why this discovery increases public health risks

The PB2-384L/443R/460M signature positively regulates the interaction between the H5N1 vRNP and human ANP32A/B proteins. It also aids in vRNP assembly, allowing the viral polymerase to utilize human proteins efficiently.

How does the H5N1 avian influenza spread? | Dr. Marla Shapiro explains

Because these substitutions can emerge while the virus is still in avian populations, the risk of zoonotic transmission is heightened. The continued evolution of H5N1 in birds may create strains that are pre-adapted for human infection.

What may happen next?

As H5N1 continues to circulate in avian populations, more viruses could potentially develop the PB2-384L/443R/460M signature or similar mutations. This may lead to an increased capacity for these viruses to interact with human proteins.

Such evolutionary shifts could likely result in a higher frequency of productive human infections. Public health risks may increase as these avian-born mutations augment the virus’s ability to replicate in mammalian hosts.

Frequently Asked Questions

What are ANP32A/B proteins?
They are species-specific acidic nuclear phosphoprotein 32 kDa members that normally restrict the function of avian influenza virus polymerase in mammalian hosts.

What is the significance of the PB2-384L/443R/460M signature?
This signature allows the H5N1 virus to efficiently utilize human ANP32A/B proteins and positively regulates vRNP assembly and interaction.

Which specific viruses were studied to find this signature?
The study analyzed A/chicken/LN/SD035/2018 (LN35) and A/duck/JL/S1261/2019 (JL261).

How should global health monitoring adapt to track mutations emerging in avian populations?